PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
מצבים רפואיים
Triple Negative Breast Cancer · Locally Advanced Breast Cancer · Recurrent Breast Cancer · Metastatic Breast Cancer · ER+ Breast Cancer · HER2-positive Breast Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
Contact: Principal Investigator (Anne Armstrong)Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Contact: Principal Investigator (Richard Baird)Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Contact: Principal Investigator (Iain MacPherson)Hope Clinical Trials Cancer Centre, Leicester, United Kingdom
Contact: Principal Investigator (Olubukola Ayodele)Barts Cancer Institute, London, United Kingdom
Contact: Principal Investigator (Peter Schmid)Royal Marsden NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Alicia Okines)University College London Hospitals NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Rebecca Roylance)Nottingham University Hospital, Nottingham, United Kingdom
Weston Park Hospital, Sheffield, United Kingdom
Contact: Principal Investigator (Matthew Winter)
מובילי המחקר
Alicia Okines
Principal Investigator
The Royal Marsden Hospital